<DOC>
	<DOCNO>NCT01058317</DOCNO>
	<brief_summary>Juvenile onset recurrent respiratory papillomatosis ( JORRP ) rare , difficult treat , benign tumor pediatric airway . Current therapy mainly surgical , significant portion patient adjuvant therapy require control disease process . Although multiple adjuvant medical therapy try , success limit . We see success limited amount patient use orally administer propranolol . Our goal enroll large cohort patient determine effectiveness propranolol adjuvant therapy JORRP .</brief_summary>
	<brief_title>Propranolol Administration Pediatric Patients With Recurrent Respiratory Papillomatosis</brief_title>
	<detailed_description />
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>1 . Biopsy proven appropriate Human Papilloma Virus type Recurrent Respiratory Papilloma 2 . Child age 10 3 . Informed consent appropriate inform assent 4 . Children undergone least 4 documented surgical intervention past year . Parental child refusal participate Heart failure Atrioventricular heart block Cardiac anomaly Low rest heart rate Low rest blood pressure WolffParkinson White Syndrome Unexplained syncope Asthma Reactive airway disease Renal liver failure Expected long fast period , &gt; 12 hour Diabetes Mellitus Hypersensitivity propranolol</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>respiratory , papilloma , pediatric , juvenile</keyword>
</DOC>